258 related articles for article (PubMed ID: 21458553)
21. Higuchi's equation and beyond: overview of the formulation and application of a generalized model of drug release from polymeric matrices.
Petropoulos JH; Papadokostaki KG; Sanopoulou M
Int J Pharm; 2012 Nov; 437(1-2):178-91. PubMed ID: 22921377
[TBL] [Abstract][Full Text] [Related]
22. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
[TBL] [Abstract][Full Text] [Related]
23. Deeper insight into the drug release mechanisms in Eudragit RL-based delivery systems.
Glaessl B; Siepmann F; Tucker I; Rades T; Siepmann J
Int J Pharm; 2010 Apr; 389(1-2):139-46. PubMed ID: 20105459
[TBL] [Abstract][Full Text] [Related]
24. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
25. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
26. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
27. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
Chen SJ; Zhu JB
Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
[TBL] [Abstract][Full Text] [Related]
28. In vitro method to characterize diffusion of dye from polymeric particles: a model for drug release.
Pancholi K; Stride E; Edirisinghe M
Langmuir; 2009 Sep; 25(17):10007-13. PubMed ID: 19658422
[TBL] [Abstract][Full Text] [Related]
29. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
30. Dissolution behaviour of sustained release formulations of indomethacin with Eudragit RS.
Khanfar MS; Salem MS; Najib NM; Pillai GK
Acta Pharm Hung; 1997 Nov; 67(6):235-9. PubMed ID: 9423295
[TBL] [Abstract][Full Text] [Related]
31. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
Maswadeh HM; Semreen MH; Abdulhalim AA
Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
[TBL] [Abstract][Full Text] [Related]
32. Release rates from topical formulations containing drugs in suspension.
Bunge AL
J Control Release; 1998 Mar; 52(1-2):141-8. PubMed ID: 9685944
[TBL] [Abstract][Full Text] [Related]
33. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
Prasad Verma PR; Chandak AR
Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
[TBL] [Abstract][Full Text] [Related]
34. A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model.
Perale G; Arosio P; Moscatelli D; Barri V; Müller M; Maccagnan S; Masi M
J Control Release; 2009 Jun; 136(3):196-205. PubMed ID: 19250952
[TBL] [Abstract][Full Text] [Related]
35. Encapsulated zinc salt increases the diffusion of protein through PLG films.
Fredenberg S; Reslow M; Axelsson A
Int J Pharm; 2009 Mar; 370(1-2):47-53. PubMed ID: 19073244
[TBL] [Abstract][Full Text] [Related]
36. Damar Batu as a novel matrix former for the transdermal drug delivery: in vitro evaluation.
Mundada AS; Avari JG
Drug Dev Ind Pharm; 2009 Sep; 35(9):1147-54. PubMed ID: 19555240
[TBL] [Abstract][Full Text] [Related]
37. Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition method.
Vachon MG; Nairn JG
J Microencapsul; 1995; 12(3):287-305. PubMed ID: 7650593
[TBL] [Abstract][Full Text] [Related]
38. A new hydrogel for the extended and complete prednisolone release in the GI tract.
Di Colo G; Baggiani A; Zambito Y; Mollica G; Geppi M; Serafini MF
Int J Pharm; 2006 Mar; 310(1-2):154-61. PubMed ID: 16414222
[TBL] [Abstract][Full Text] [Related]
39. Theory of effective drug release from medical implants based on the Higuchi model and physico-chemical hydrodynamics.
Dukhin SS; Labib ME
Colloids Surf A Physicochem Eng Asp; 2012 Sep; 409():10-20. PubMed ID: 24155569
[TBL] [Abstract][Full Text] [Related]
40. Kinetic Release Studies of Antibiotic Patches for Local Transdermal Delivery.
Altun E; Yuca E; Ekren N; Kalaskar DM; Ficai D; Dolete G; Ficai A; Gunduz O
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33922739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
